全文获取类型
收费全文 | 6201篇 |
免费 | 357篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 157篇 |
妇产科学 | 158篇 |
基础医学 | 1256篇 |
口腔科学 | 146篇 |
临床医学 | 589篇 |
内科学 | 1028篇 |
皮肤病学 | 81篇 |
神经病学 | 511篇 |
特种医学 | 181篇 |
外科学 | 603篇 |
综合类 | 53篇 |
一般理论 | 2篇 |
预防医学 | 498篇 |
眼科学 | 209篇 |
药学 | 493篇 |
中国医学 | 6篇 |
肿瘤学 | 532篇 |
出版年
2022年 | 59篇 |
2021年 | 78篇 |
2020年 | 62篇 |
2019年 | 104篇 |
2018年 | 112篇 |
2017年 | 76篇 |
2016年 | 93篇 |
2015年 | 98篇 |
2014年 | 121篇 |
2013年 | 192篇 |
2012年 | 218篇 |
2011年 | 259篇 |
2010年 | 216篇 |
2009年 | 154篇 |
2008年 | 272篇 |
2007年 | 246篇 |
2006年 | 230篇 |
2005年 | 210篇 |
2004年 | 248篇 |
2003年 | 229篇 |
2002年 | 284篇 |
2001年 | 144篇 |
2000年 | 143篇 |
1999年 | 132篇 |
1998年 | 68篇 |
1995年 | 49篇 |
1994年 | 45篇 |
1993年 | 45篇 |
1992年 | 103篇 |
1991年 | 90篇 |
1990年 | 82篇 |
1989年 | 81篇 |
1988年 | 85篇 |
1987年 | 88篇 |
1986年 | 68篇 |
1985年 | 78篇 |
1984年 | 48篇 |
1983年 | 49篇 |
1980年 | 54篇 |
1979年 | 53篇 |
1978年 | 44篇 |
1974年 | 67篇 |
1973年 | 41篇 |
1972年 | 51篇 |
1971年 | 72篇 |
1970年 | 92篇 |
1969年 | 109篇 |
1968年 | 108篇 |
1967年 | 127篇 |
1966年 | 130篇 |
排序方式: 共有6569条查询结果,搜索用时 15 毫秒
1.
2.
3.
Setting goals to maintain hope. 总被引:3,自引:0,他引:3
4.
Brahma.S. Sharma Supryia Mhaskar Louisa Balazs Martin Siaw 《Immunopharmacology and immunotoxicology》1992,14(1):1-19
We reported recently that a novel immunomodulator, 7-thia-8-oxoguanosine (7T80G)2 inhibited formation of pulmonary melanoma metastases (1), prevented against viral infection in mice (2) and potentiated the efficacy of a weakly immunogenic leukemia vaccine (3). Since certain tumor metastases and virus infected cells are targets to natural killer cells (NK cells), we now investigated whether 7T80G is capable of activating NK cells in mice using NK cell sensitive YAC-1 and B16 and NK cell insensitive P815 targets. CBA/CaJ spleen cells incubated in vitro with 7T80G at concentrations ranging from 0.005 to 0.5 mM responded with increased NK cell activity (32-62 %) compared to controls (4-8%) to YAC-1 targets. Similar levels of augmentation in NK cell activity were observed when 40-168 mg/kg of 7T80G was administered in vivo. In addition to the spleen, 7T80G activated NK cells in the bone marrow (BM), the lungs, the liver, and in peritoneal exudate cells (PE). Although 7T80G elicited activation of NK cells was observed as early as three hours after treatment, the maximal activity was observed after 24 h in the spleen; 12 h in the BM; 48 h in the lungs, and 72 h in PE. Administration of the drug by s.c, i.v., and i.p. routes all induced activition of NK cells in spleen, BM and PE. 7T80G was found to activate NK cells in seven inbred and an outbred mouse strain, suggesting that the induced cytotoxicity against allogeneic and syngeneic tumor cells is not strain specific as well as independent of MHC restriction. C3H/He, CBA/CaJ and BDF/1 displayed higher levels of increased NK cell activity, whereas AKR mice were low responders. Low concentrations of IL-2 (0.25-5 U/ml) that induce little or no NK cell activity, when used in combination with 7T80G, elicited significant enhancement of NK cell cytotoxicity. In contrast, IFN and 7T80G showed no such synergism. 相似文献
5.
6.
Abstract – Aim: To evaluate the pulp and periodontal healing of laterally luxated permanent teeth. Material and methods: Patients presenting with lateral luxation of permanent teeth during 2001–2002 were enrolled in this clinical study. Laterally luxated teeth were repositioned and splinted with a TTS/composite resin splint for 4 weeks. Immediate (prophylactic) root‐canal treatment was performed in severely luxated teeth with radiographically closed apices. All patients received tetracycline for 10 days. Re‐examinations were performed after 1, 2, 3, 6, 12 and 48 months. Results: All 47 laterally luxated permanent teeth that could be followed over the entire study period survived. In 10 teeth (21.3%), a prophylactic root‐canal treatment was performed within 2 weeks following injury. The remaining 37 teeth showed the following characteristics at the 4‐year re‐examination: 19 teeth (51.4%) had pulp survival (no clinical or radiographic signs or symptoms), nine teeth (24.3%) presented with pulp canal calcification, and pulp necrosis was seen in another nine teeth (24.3%), within the first year after trauma. None of the teeth with a radiographically open apex at the time of lateral luxation showed complications. External root resorption was only seen in one tooth. Conclusions: Laterally luxated permanent teeth with incomplete root formation have a good prognosis, with all teeth surviving in this study. The most frequent complication was pulp necrosis that was only seen in teeth with closed apices. 相似文献
7.
A. Fuerst S. Derungs B.
Von Rechenberg J. A. Auer J. Schense J. Watson 《Transboundary and Emerging Diseases》2007,54(2):107-112
To describe the treatment of a subchondral bone cyst in the proximal phalanx with parathyroid hormone peptide‐enriched fibrin hydrogel in a warmblood filly. The cyst was localized with computer‐assisted orthopaedic surgery, then curetted and finally filled with parathyroid hormone fragment peptide 1–34 (PTH1−34) covalently attached to a fibrin hydrogel. The cyst healed quickly without any complications. This result supports the hypothesis that PTH1−34 delivered locally in a fibrin hydrogel may improve the postoperative prognosis of surgical management of subchondral bone cysts in horses. Subchondral bone cysts are fairly common in horses. Especially in older horses, the prognosis is poor, even after surgical curettage. Therefore, different management protocols have been investigated in conjunction with surgical curettage to improve prognosis. Locally delivered PTH1−34 seems to be a new method in the treatment of subchondral bone cysts. 相似文献
8.
9.
Jennifer P. Friedberg Marios N. Adonis Heather A. Von Bergen Sonia Suchday 《Stress and health》2005,21(1):53-60
Exposure to trauma and stress has been linked with poor health, while forgiveness appears to be positively associated with health outcomes. The current study investigates whether traits such as forgiveness and ruminative tendencies predict levels of trauma and stress experienced by New York City residents on the 1‐year anniversary of the September 11th terrorist attack. Seventy‐one students and staff members (57 females, 14 males) of a graduate school in New York City were administered the Impact of Events Scale, the Perceived Stress Scale, and questionnaires designed for the purpose of this study to measure ruminative tendencies and forgiveness on September 11, 2002. Rumination predicted levels of trauma (p < 0.05) and perceived stress (p < 0.01). Lower levels of forgiveness predicted perceived stress (p < 0.05), but not trauma. Rumination mediated the relationship between forgiveness and perceived stress. These findings suggest that individuals with higher levels of rumination have an elevated risk of experiencing trauma and stress‐related symptoms following a traumatic event. Forgiveness is associated with lower levels of stress, but not trauma, perhaps because trauma is an extreme form of stress. Forgiveness appears to serve as a buffer against stress more so in individuals with low levels of rumination than in individuals with high levels of rumination. Copyright © 2005 John Wiley & Sons, Ltd. 相似文献
10.
Response rates,duration of response,and dose response effects in phase I studies of antineoplastics 总被引:4,自引:0,他引:4
Summary Over a period of 14 years, 7,960 patients were treated in 228 phase I trials. In these patients, there were 75 complete and 432 partial responses for an overall objective response rate of 6%. Complete responses lasted a median of six months (range 1–18), while partial responses lasted a median of three months (range 1–17). Of note is that no drug has made it to the market which has not had a response in phase I trials. Responses were noted in very diverse histologic types of tumors. Although there were responses at doses which were as low as 3–5% of the recommended dose for phase II trials, the majority of responses did occur at 80–120% of the dose recommended for phase II trials. Although the response rate in phase I trials is indeed low, responses do occur. This response rate information should help the clinician provide facts for the patient considering a phase I trial with new anticancer agents. These findings also emphasize that although phase I trials are characteristically dose-finding studies, if no responses are noted in phase I studies, it is unlikely the drug will be used routinely in the clinic. 相似文献